文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

阿片类药物使用与COVID-19预后:系统评价与荟萃分析

Opioid usage and COVID-19 prognosis: A systematic review and meta-analysis.
PubMed 文献 · Am J Emerg Med · 2022-03-27
一句话结论荟萃分析显示,阿片类药物使用与COVID-19患者ICU入住(OR=5.41)和死亡(OR=2.74)风险升高相关,但与机械通气需求无显著关联。

该研究系统检索了七个健康科学数据库(截至2021年12月15日),纳入5篇相关文献。荟萃分析显示,阿片类药物使用与COVID-19患者ICU入住显著相关(OR=5.41,95%CI:1.85至15.79,P=0.002),与死亡率升高相关(OR=2.74,95%CI:1.34至5.62,P=0.034),与机械通气需求无显著关联(OR=3.68,95%CI:0.85至15.90,P=0.081)。校正分析显示,有阿片类药物使用史的COVID-19患者更可能入住ICU(OR=3.57,95%CI:3.05至4.17,P<0.001)且死亡率更高(OR=1.72,95%CI:1.09至2.72,P=0.02),与机械通气需求仍无显著关联(OR=2.09,95%CI:0.77至5.64,P=0.146)。纳入研究间存在显著异质性。

要点

  • 阿片类药物使用与COVID-19患者ICU入住风险升高相关(OR=5.41,95%CI:1.85至15.79,P=0.002)。
  • 阿片类药物使用与COVID-19患者死亡风险升高相关(OR=2.74,95%CI:1.34至5.62,P=0.034)。
  • 校正分析中,有阿片类药物使用史者ICU入住风险更高(OR=3.57,95%CI:3.05至4.17,P<0.001),死亡风险更高(OR=1.72,95%CI:1.09至2.72,P=0.02)。
  • 阿片类药物使用与机械通气需求无显著关联(未校正OR=3.68,95%CI:0.85至15.90,P=0.081;校正OR=2.09,95%CI:0.77至5.64,P=0.146)。
  • 纳入研究间存在显著异质性,作者认为需前瞻性研究确认上述发现。

适用人群与场景

  • COVID-19患者,按是否有阿片类药物使用或使用史进行分组比较。

研究设计与关键结果

  • 系统评价与荟萃分析,共纳入5篇相关文献,检索七个健康科学数据库(包括PubMed、Embase、Cochrane Library、Web of Science、中国知网、万方数据)截至2021年12月15日。
  • 阿片类药物使用与COVID-19患者ICU入住显著相关(OR=5.41,95%CI:1.85至15.79,P=0.002)。
  • 阿片类药物使用与COVID-19患者死亡风险升高相关(OR=2.74,95%CI:1.34至5.62,P=0.034)。
  • 阿片类药物使用与机械通气需求无显著关联(OR=3.68,95%CI:0.85至15.90,P=0.081)。
  • 校正分析显示,有阿片类药物使用史的COVID-19患者更可能入住ICU(OR=3.57,95%CI:3.05至4.17,P<0.001)且死亡率更高(OR=1.72,95%CI:1.09至2.72,P=0.02),与机械通气需求无显著关联(OR=2.09,95%CI:0.77至5.64,P=0.146)。
  • 纳入研究间存在显著异质性。

证据类型、等级与局限

  • 证据类型:系统评价与荟萃分析。
  • 纳入研究间存在显著异质性。
  • 作者认为需前瞻性研究确认上述发现。
  • 局限:原文未报告其他局限性。

对床旁实践的改变

  • 对于COVID-19患者,阿片类药物使用或使用史可能与ICU入住和死亡风险升高相关,临床中可据此识别高危患者。
  • 阿片类药物使用与机械通气需求无显著关联,不能据此认为阿片类药物使用会增加或降低机械通气风险。
  • 作者认为需前瞻性研究确认上述发现。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

The COVID-19 pandemic continues to have profound health, social, psychological, and economic ramifications. Infection by COVID-19 has been of concern in people who use opioids, as opioid use has been known to mediate immunosuppression and is associated with respiratory depression and end-organ damage. With differing modalities of opioid usage, the association between opioids and COVID-19 outcomes is not well understood. We performed a comprehensive systematic search of seven health science databases, including PubMed, Embase, Cochrane Library, Web of Science, China National Knowledge Infrastructure (CNKI), and Wanfang Data, up to December 15, 2021. We identified a total of five related articles, which were included in this study. The meta-analysis showed that opioids have a significant association with ICU admission for COVID-19 patients (OR = 5.41, 95%CI: 1.85 to 15.79, P = 0.002). Use of opioids was also associated with higher mortality among patients with COVID-19 compared to non-users (OR = 2.74, 95%CI: 1.34 to 5.62, P = 0.034), while use of opioids was not significantly associated with need for mechanical ventilation (OR = 3.68, 95%CI: 0.85 to 15.90, P = 0.081). Furthermore, the adjusted analysis indicated that COVID-19 patients with a history of opioid use were more likely to be admitted to the ICU (OR = 3.57, 95%CI: 3.05 to 4.17, P<0.001) and have higher mortality rates (OR = 1.72, 95%CI: 1.09 to 2.72, P = 0.02), while there was no significant association with need for mechanical ventilation (OR = 2.09, 95%CI: 0.77 to 5.64, P = 0.146). Significant heterogeneity existed across the included studies. Patients using opioids with COVID-19 were at higher risk of ICU admission and mortality. Prospective studies are required to confirm these findings.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Ao G, Li T, Wang Y, et al. Opioid usage and COVID-19 prognosis: A systematic review and meta-analysis. Am J Emerg Med. 2022. PMID: 35366438. doi:10.1016/j.ajem.2022.03.048

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。